Apr 27, 2023
- Corporate
Organizational and Personnel Changes
TOKYO, April 27, 2023 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following organizational and personnel changes, effective July 1, 2023.
[Details of Organizational Changes]
1. Establishment of Business Transformation Dept.
ASPIRE* Transformation (AX) Dept. has been established to implement the next-generation core business infrastructure (ERP: enterprise resource planning system) and to conduct company-wide reforms of business processes and organizations, effective January 1, 2023. Business Transformation (BX) Dept. will be newly established as an organization responsible for transforming business processes that conform to the new operating model and establishing a process management structure, in order to increase the operational efficiency of the entire Chugai Group with the activities of ASPIRE program as the starting point. The company-wide transformation will be advanced under the two frameworks for action, AX and BX.
- Business Transformation Dept. will be newly established.
2. Reorganization of the Research Div.
To strengthen the pharmacology functions, improve organizational management and promote the integration of drug discovery technologies over therapeutic areas, Discovery Pharmacology 1 Dept. and Discovery Pharmacology 2 Dept. will be newly established, and Discovery Pharmacology Dept. will be dissolved. Specialty (i.e., excluding oncology) and Oncology functions will be retained in each new department.
- Discovery Pharmacology 1 Dept. will be newly established.
- Discovery Pharmacology 2 Dept. will be newly established.
- Discovery Pharmacology Dept. will be dissolved.
[Details of Personnel Changes]
Director
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Osamu Okuda |
Representative Director, President |
Representative Director, President |
Vice President
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Norihisa Onozawa |
Vice President |
Vice President |
Please see the PDF file about other personnel changes.
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
